Pioneering new technology to develop next-generation cancer therapies

Reverie Labs is a pharmaceutical company that uses its innovative computational chemistry and machine learning tools to accelerate its drug discovery programs. Reverie's primary goal is to develop kinase inhibitors that address the unmet needs of patients.
Backed by

A paradigm shift in designing kinase inhibitors

Reverie Labs places computation, chemistry, and creativity at the center of drug discovery. We work as a team to understand and solve the complexities of cancer — better, faster, and more efficiently.

Our company

Powering the next generation of drug discovery and design

Reverie’s drug discovery programs sit on top of our extensive and rapidly growing technology platform, consisting of predictive tools, novel methods for focused molecular generation, and expansive proprietary datasets. With this foundation, our team brings new therapies to patients.

Learn more
Supervised Machine Learning
Virtual
Screening
Computational Chemistry & Modeling
Representation & Visualization
Algorithmic Molecular Generation
Supervised Machine Learning

Powering the next generation of drug discovery and design.

Reverie Labs has united a multidisciplinary team of world-class engineers, chemists, and modelers who work together daily to meet the rigorous demands and unique constraints of drug discovery.

Driven by technology and teamwork

Reverie Labs has united a multidisciplinary team of world-class engineers, chemists, and modelers who work together daily to meet the rigorous demands and unique constraints of drug discovery.

Join us in our mission to fight cancer.